home / stock / annx / annx short
Short Information | Annexon Inc. (NASDAQ:ANNX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 2,323,183 |
Total Actual Volume | 18,486,306 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 116,159 |
Average Short Percentage | 13.50% |
Is there a ANNX Short Squeeze or Breakout about to happen?
See the ANNX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
09-10-2024 | $6.24 | $6.25 | $6.3657 | $6.12 | 573,823 | 77,279 | 13.47% |
09-09-2024 | $5.78 | $6.22 | $6.35 | $5.77 | 876,532 | 105,182 | 12% |
09-06-2024 | $5.85 | $5.75 | $6 | $5.535 | 612,633 | 109,248 | 17.83% |
09-05-2024 | $5.59 | $5.82 | $5.9 | $5.56 | 901,869 | 149,803 | 16.61% |
09-04-2024 | $5.41 | $5.59 | $5.63 | $5.31 | 586,051 | 115,006 | 19.62% |
09-03-2024 | $5.61 | $5.41 | $5.72 | $5.38 | 1,026,741 | 180,070 | 17.54% |
08-30-2024 | $5.97 | $5.7 | $6.04 | $5.66 | 614,381 | 98,755 | 16.07% |
08-29-2024 | $5.95 | $5.93 | $6.205 | $5.92 | 684,075 | 67,915 | 9.93% |
08-28-2024 | $5.99 | $5.94 | $6.12 | $5.83 | 682,207 | 89,409 | 13.11% |
08-27-2024 | $5.93 | $6.05 | $6.18 | $5.81 | 554,817 | 89,123 | 16.06% |
08-26-2024 | $5.92 | $6.11 | $6.2486 | $5.88 | 1,150,977 | 89,024 | 7.73% |
08-23-2024 | $5.81 | $5.89 | $6 | $5.71 | 1,212,073 | 143,639 | 11.85% |
08-22-2024 | $5.91 | $5.8 | $6.01 | $5.68 | 609,080 | 104,556 | 17.17% |
08-21-2024 | $5.99 | $5.91 | $6.16 | $5.9 | 1,457,076 | 136,814 | 9.39% |
08-20-2024 | $5.93 | $5.99 | $6.13 | $5.75 | 1,414,808 | 190,366 | 13.46% |
08-19-2024 | $6.12 | $5.98 | $6.3 | $5.7919 | 1,686,404 | 156,780 | 9.3% |
08-16-2024 | $5.97 | $6.1 | $6.23 | $5.96 | 766,743 | 100,723 | 13.14% |
08-15-2024 | $5.78 | $5.98 | $6.03 | $5.74 | 1,534,964 | 100,654 | 6.56% |
08-14-2024 | $5.68 | $5.61 | $5.73 | $5.37 | 662,901 | 116,675 | 17.6% |
08-13-2024 | $5.55 | $5.685 | $5.89 | $5.55 | 878,151 | 102,162 | 11.63% |
News, Short Squeeze, Breakout and More Instantly...
Only Program that has Demonstrated Significant Vision Protection in Standard and Low Light Conditions and Significant Preservation of Photoreceptors in the Fovea Region Critical for Visual Acuity ARCHER II Phase 3 Pivotal Program in GA Underway with Data Expected Second Half 2026 ...
BRISBANE, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing novel complement therapies for neuroinflammatory diseases of the body, brain, and eye, today announced the strengthening of its senior leadership team with the appointment ...
BRISBANE, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing novel complement therapies for neuroinflammatory diseases of the body, brain and eye, today announced that Douglas Love, Esq., president & chief executive officer, will part...